Followers | 1610 |
Posts | 118779 |
Boards Moderated | 20 |
Alias Born | 08/20/2006 |
Wednesday, July 01, 2020 2:59:36 PM
Reporting Period: 06/01/2020 to 06/30/2020
Proceeds
$3,586,089.38
Cost Basis
$2,465,659.64
Total Gain/Loss
+$1,121,738.50 (46%)
Long Term Gain/Loss
$0.00 (N/A)
Short Term Gain/Loss
+$1,121,738.50 (46%)
$RLBY
Recent RLBY News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 04:20:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 09:30:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/19/2023 08:56:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 05:18:54 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM